Search Results - "PELICANO, Hélène"

Refine Results
  1. 1

    Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential by Pelicano, Hélène, Zhang, Wan, Liu, Jinyun, Hammoudi, Naima, Dai, Jiale, Xu, Rui-Hua, Pusztai, Lajos, Huang, Peng

    Published in Breast cancer research : BCR (11-09-2014)
    “…Triple-negative breast cancer (TNBC) is a subtype of highly malignant breast cancer with poor prognosis. TNBC is not amenable to endocrine therapy and often…”
    Get full text
    Journal Article
  2. 2

    Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism by Pelicano, Hélène, Xu, Rui-hua, Du, Min, Feng, Li, Sasaki, Ryohei, Carew, Jennifer S, Hu, Yumin, Ramdas, Latha, Hu, Limei, Keating, Michael J, Zhang, Wei, Plunkett, William, Huang, Peng

    Published in The Journal of cell biology (18-12-2006)
    “…Cancer cells exhibit increased glycolysis for ATP production due, in part, to respiration injury (the Warburg effect). Because ATP generation through…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Cancer Metabolism: Is Glutamine Sweeter than Glucose? by Lu, Weiqin, Pelicano, Helene, Huang, Peng

    Published in Cancer cell (14-09-2010)
    “…Glutamine is an essential nutrient for cancer cells. In this issue of Cancer Cell, Wang et al. (2010) show that malignant transformation by Rho GTPases leads…”
    Get full text
    Journal Article
  6. 6

    ROS stress in cancer cells and therapeutic implications by Pelicano, Helene, Carney, Dennis, Huang, Peng

    Published in Drug resistance updates (01-04-2004)
    “…Reactive oxygen species (ROS) are constantly generated and eliminated in the biological system, and play important roles in a variety of normal biochemical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Novel action of paclitaxel against cancer cells : Bystander effect mediated by reactive oxygen species by ALEXANDRE, Jérome, YUMIN HU, WEIQIN LU, PELICANO, Helene, PENG HUANG

    Published in Cancer research (Chicago, Ill.) (15-04-2007)
    “…Generation of reactive oxygen species (ROS) has been observed in cancer cells treated with paclitaxel, but the underlying mechanisms and therapeutic…”
    Get full text
    Journal Article
  9. 9

    Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism by PELICANO, Helene, WEIQIN LU, YAN ZHOU, WAN ZHANG, ZHAO CHEN, YUMIN HU, PENG HUANG

    Published in Cancer research (Chicago, Ill.) (15-03-2009)
    “…Although mitochondrial dysfunction and reactive oxygen species (ROS) stress have long been observed in cancer cells, their role in promoting malignant cell…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy by Lu, Weiqin, Hu, Yumin, Chen, Gang, Chen, Zhao, Zhang, Hui, Wang, Feng, Feng, Li, Pelicano, Helene, Wang, Hua, Keating, Michael J, Liu, Jinsong, McKeehan, Wallace, Wang, Huamin, Luo, Yongde, Huang, Peng

    Published in PLoS biology (01-05-2012)
    “…Elevated aerobic glycolysis in cancer cells (the Warburg effect) may be attributed to respiration injury or mitochondrial dysfunction, but the underlying…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway by Honeychurch, Jamie, Alduaij, Waleed, Azizyan, Mahsa, Cheadle, Eleanor J., Pelicano, Helene, Ivanov, Andrei, Huang, Peng, Cragg, Mark S., Illidge, Tim M.

    Published in Blood (12-04-2012)
    “…Monoclonal antibodies (mAbs) have revolutionized the treatment of B-cell malignancies. Although Fc-dependent mechanisms of mAb-mediated tumor clearance have…”
    Get full text
    Journal Article
  14. 14

    Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism by Trachootham, Dunyaporn, Zhang, Hui, Zhang, Wan, Feng, Li, Du, Min, Zhou, Yan, Chen, Zhao, Pelicano, Helene, Plunkett, William, Wierda, William G., Keating, Michael J., Huang, Peng

    Published in Blood (01-09-2008)
    “…Chronic lymphocytic leukemia (CLL) is the most common adult leukemia, and resistance to fludarabine-based therapies is a major challenge in CLL treatment…”
    Get full text
    Journal Article
  15. 15

    The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo by Fu, Loning, Pelicano, Helene, Liu, Jinsong, Huang, Peng, Lee, Cheng Chi

    Published in Cell (04-10-2002)
    “…The Period2 gene plays a key role in controlling circadian rhythm in mice. We report here that mice deficient in the mPer2 gene are cancer prone. After γ…”
    Get full text
    Journal Article
  16. 16

    Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications by Ju, Huai-Qiang, Lu, Yun-Xin, Chen, Dong-Liang, Tian, Tian, Mo, Hai-Yu, Wei, Xiao-Li, Liao, Jian-Wei, Wang, Feng, Zeng, Zhao-Lei, Pelicano, Helene, Aguilar, Mitzi, Jia, Wei-Hua, Xu, Rui-Hua

    Published in Theranostics (01-01-2016)
    “…Colorectal cancer (CRC) is a common neoplastic disease and a frequent cause of death. Drug resistance is a major challenge to CRC treatment and stem-like…”
    Get full text
    Journal Article
  17. 17

    microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer by Chen, Dong-liang, Zhang, Dong-sheng, Lu, Yun-xin, Chen, Le-zong, Zeng, Zhao-lei, He, Ming-ming, Wang, Feng-hua, Li, Yu-hong, Zhang, Hui-zhong, Pelicano, Helene, Zhang, Wei, Xu, Rui-hua

    Published in Oncotarget (10-05-2015)
    “…microRNA-217 (miR-217) is frequently dysregulated in cancer. Here, we report that miR-217 levels were lower in tumor tissue compared with the adjacent normal…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20